351 related articles for article (PubMed ID: 21486728)
1. Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
Karthaus M
Eur J Med Res; 2011 Apr; 16(4):145-52. PubMed ID: 21486728
[TBL] [Abstract][Full Text] [Related]
2. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
Ament AJ; Hübben MW; Verweij PE; de Groot R; Warris A; Donnelly JP; van 't Wout J; Severens JL
J Antimicrob Chemother; 2007 Aug; 60(2):385-93. PubMed ID: 17561501
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.
Chabrol A; Cuzin L; Huguet F; Alvarez M; Verdeil X; Linas MD; Cassaing S; Giron J; Tetu L; Attal M; Récher C
Haematologica; 2010 Jun; 95(6):996-1003. PubMed ID: 20007135
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Belgium.
Selleslag D; Vogelaers D; Marbaix S
Acta Clin Belg; 2009; 64(5):393-8. PubMed ID: 19999386
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
Clemons KV; Schwartz JA; Stevens DA
Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
[TBL] [Abstract][Full Text] [Related]
8. Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole.
Gubler C; Wildi SM; Imhof A; Schneemann M; Müllhaupt B
Infection; 2007 Oct; 35(5):364-6. PubMed ID: 17721739
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Clemons KV; Espiritu M; Parmar R; Stevens DA
Antimicrob Agents Chemother; 2005 Dec; 49(12):4867-75. PubMed ID: 16304147
[TBL] [Abstract][Full Text] [Related]
10. Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
Bourke P; Castro P; Rabagliati R; Beltran C; Verdejo H; Winter JL; Bourge RC
Transpl Infect Dis; 2012 Oct; 14(5):E56-9. PubMed ID: 22852999
[TBL] [Abstract][Full Text] [Related]
11. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
12. Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
Steinbach WJ
Curr Drug Targets Infect Disord; 2005 Sep; 5(3):203-10. PubMed ID: 16181140
[TBL] [Abstract][Full Text] [Related]
13. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
[TBL] [Abstract][Full Text] [Related]
14. Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient.
Beiras-Fernandez A; Bigdeli AK; Nickel T; Michel S; Ueberfuhr P; Reichart B; Kaczmarek I
Exp Clin Transplant; 2011 Aug; 9(4):279-83. PubMed ID: 21819376
[TBL] [Abstract][Full Text] [Related]
15. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Sims-McCallum RP
Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986
[No Abstract] [Full Text] [Related]
16. Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review.
Xu XY; Sun HM; Zhao BL; Shi Y
J Mycol Med; 2013 Mar; 23(1):64-9. PubMed ID: 23375859
[TBL] [Abstract][Full Text] [Related]
17. Combination antifungal therapy for invasive aspergillosis.
Marr KA; Boeckh M; Carter RA; Kim HW; Corey L
Clin Infect Dis; 2004 Sep; 39(6):797-802. PubMed ID: 15472810
[TBL] [Abstract][Full Text] [Related]
18. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
Pagano L; Caira M; Candoni A; Offidani M; Martino B; Specchia G; Pastore D; Stanzani M; Cattaneo C; Fanci R; Caramatti C; Rossini F; Luppi M; Potenza L; Ferrara F; Mitra ME; Fadda RM; Invernizzi R; Aloisi T; Picardi M; Bonini A; Vacca A; Chierichini A; Melillo L; de Waure C; Fianchi L; Riva M; Leone G; Aversa F; Nosari A
Haematologica; 2010 Apr; 95(4):644-50. PubMed ID: 19850903
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Perea S; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2002 Aug; 46(8):2564-8. PubMed ID: 12121933
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature.
Sandherr M; Maschmeyer G
Eur J Med Res; 2011 Apr; 16(4):139-44. PubMed ID: 21486727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
